Pediatrix Medical Group, Inc.

MD Healthcare Medical Care Facilities

Pediatrix Medical Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, down 4.92% from fiscal 2024.

Revenue
+1.72%
EPS
−27.6%
Free cash flow
−14.4%
Total debt
−4.11%

Quarter to September 2026, against a year earlier

31.73 1.07 −3.26%
Market cap
$2.5B
P/E
17.1×
Fwd P/E
15.3×
Dividend yield
—
F-score
7/9
Altman Z
2.05
Beneish M
−2.86
Dividend safety
n/a

Pediatrix Medical Group, Inc. (MD) EBITDA

Alert me on EBITDA

Pediatrix Medical Group, Inc.'s EBITDA for fiscal 2025 was $231.6M, compared with −$35.5M in fiscal 2024. Over the twelve months to 30 September 2026 it was $236.8M. Over the past ten years it has ranged from −$35.5M (fiscal 2024) to $665.8M (fiscal 2016); the current reading is higher than 55% of that period. Pediatrix Medical Group, Inc. ranks 22nd of 48 Medical Care Facilities companies by EBITDA.

EBITDA, annual

Embed this chart

Annual newest first

Period EBITDA Change
FY2025 $231.6M —
FY2024 −$35.5M —
FY2023 $44.7M (78.71%)
FY2022 $210.1M (12.24%)
FY2021 $239.4M 79.01%
FY2020 $133.7M (34.24%)
FY2019 $203.4M (26.67%)
FY2018 $277.3M (48.58%)
FY2017 $539.3M (19.00%)
FY2016 $665.8M 6.76%

Quarterly newest first

Period EBITDA Change
Sep 2026 $71.5M 13.96%
Jun 2026 $62.8M 31.07%
Mar 2026 $47.9M (12.41%)
Dec 2025 $54.7M (25.97%)
43 more quarters

Against its own ten years

Low −$35.5M High $665.8M
Ten-year median $231.6M
Current reading's percentile 55

EBITDA against peers

What EBITDA is

EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.

Reported line item

The full definition of EBITDA →

More on MD